Reimbursement for CAS in the USA could be tied to accountability

768


Recent technological advancements, including the use of micromesh stents, greater adoption of proximal protection and new techniques such as transcarotid artery revascularisation (TCAR) are taking the field of carotid artery stenting (CAS) forward. A major advance will be getting reimbursement for CAS in the USA, and it might be that this will be linked to operator experience and adjudicated outcomes, Chris Metzger (Kingsport, USA) tells Vascular News at LINC 2019.

(Visited 248 times, 1 visits today)

LEAVE A REPLY

Please enter your comment!
Please enter your name here